Flatley Discovery Lab, LLC
Records under this name other than the patents Flatley Discovery Lab, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.
Back to Flatley Discovery Lab, LLC
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,573,948 | Triazolopyridine compounds and methods for the treatment of cystic fibrosis Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,926,315 | Triazolopyridine compounds and methods for the treatment of cystic fibrosis Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,472,357 | Triazolopyridine compounds and methods for the treatment of cystic fibrosis Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,072,017 | Compounds and Methods for the Treatment of Cystic Fibrosis Lapsed on the fee record Ended Sep 11, 2026 · High confidence | Lapsed on the fee record | Ended Sep 11, 2026 | High confidence |
| US 9,944,603 | Compounds and methods for the treatment of cystic fibrosis Lapsed on the fee record Ended Apr 17, 2026 · From the USPTO record | Lapsed on the fee record | Ended Apr 17, 2026 | From the USPTO record |
| US 9,855,249 | Isoxazole compounds and methods for the treatment of cystic fibrosis Lapsed on the fee record Ended Jan 2, 2026 · From the USPTO record | Lapsed on the fee record | Ended Jan 2, 2026 | From the USPTO record |
| US 9,790,215 | Pyridazinone compounds and methods for the treatment of cystic fibrosis Lapsed on the fee record Ended Oct 17, 2025 · From the USPTO record | Lapsed on the fee record | Ended Oct 17, 2025 | From the USPTO record |
| US 9,783,529 | Pyridazinone compounds and methods for the treatment of cystic fibrosis Lapsed on the fee record Ended Oct 10, 2025 · From the USPTO record | Lapsed on the fee record | Ended Oct 10, 2025 | From the USPTO record |
| US 9,771,327 | Compounds and methods for the treatment of cystic fibrosis Lapsed on the fee record Ended Sep 26, 2025 · From the USPTO record | Lapsed on the fee record | Ended Sep 26, 2025 | From the USPTO record |
| US 9,682,969 | Phthalazinone compounds and methods for the treatment of cystic fibrosis Lapsed on the fee record Ended Jun 20, 2025 · From the USPTO record | Lapsed on the fee record | Ended Jun 20, 2025 | From the USPTO record |